Related Experiment Video
Updated: Aug 2, 2026
04:46
'Boden Food Plate': Novel Interactive Web-based Method for the Assessment of Dietary Intake
Published on: September 18, 2018
[Clinical and pharmacological databases for personal digital assistants]
C Ibáñez Collado1, J C Juárez Giménez, J Monterde Junyent
1Servicio de Farmacia, Hospital Universitario Vall d'Hebron, 08035 Barcelona, España.
Anales De Pediatria (Barcelona, Spain : 2003)
|June 2, 2005
Summary
Personal digital assistants (PDAs) offer improved access to medical databases for healthcare professionals. This review identifies 46 PDA applications for pediatric and adult clinical decision support, drug information, and medical calculations.
Area of Science:
- Medical Informatics
- Digital Health Technologies
- Clinical Decision Support
Context:
- Personal digital assistants (PDAs) represent emerging technologies in medicine.
- These devices can enhance access to and management of diverse medical databases.
- The utility of PDAs for accessing specialized pediatric, clinical, and pharmacological information is explored.
Purpose:
- To review the technical features and applications of PDAs in medicine.
- To identify and categorize useful PDA-based medical applications.
- To assess the value of PDAs for healthcare professionals, particularly in pediatrics.
Summary:
- A comprehensive search identified 46 relevant PDA applications from 1999-2004.
- Applications include pediatric guidelines, drug databases, diagnostic tools, and medical calculators.
- Detailed information on each application's content, requirements, and source is provided.
Impact:
- Highlights the wide availability of pediatric software for PDAs.
- Empowers users to select the most suitable applications based on individual needs after quality assessment.
- Facilitates informed adoption of mobile health technologies for improved patient care.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...